Download PDF
Thromb Haemost 1960; 4(02): 149-166
DOI: 10.1055/s-0038-1654493
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

The Effect of Alimentary Hyperlipemia on Thrombolysis in vivo

Nils U. Bang   *
1   Clotting Mechanisms Section, Division of Experimental Surgery and Physiology of the Sloan-Kettering Institute for Cancer Research, New York, N. Y.
,
Eugene E. Cliffton   **
1   Clotting Mechanisms Section, Division of Experimental Surgery and Physiology of the Sloan-Kettering Institute for Cancer Research, New York, N. Y.
› Author Affiliations
Further Information

Publication History

Publication Date:
17 June 2018 (online)

    Permissions and Reprints

Summary

1. The effect of a standard, potent fibrinolytic enzyme therapy has been compared in fasting and lipemic dogs.

2. The standard fibrinolytic regimen resulted in the complete dissolution of all clots produced experimentally in the fasting state in 10 dogs.

3. Clots formed during alimentary lipemia exhibited a markedly increased resistance to the standard fibrinolytic regimen in 6 dogs.

4. An increase in anti plasmin fibrinolytic titer with concomitant decrease in spontaneous fibrinolytic activity was observed in 15 dogs following the administration of a fatty meal. No difference in fibrinolytic activity and APF titer was demonstrable in fasting and lipemic blood samples obtained during fibrinolytic enzyme treatment.

5. The possibility of the presence of specific inhibitors against the fibrinolytic enzyme in clots formed during lipemia has been investigated and the evidence to support this theory is discussed.

* Research Fellow, Sloan-Kettering Institute, New York, N. Y.


** Assoc. Prof. of Clinical Surgery, Cornell U. School of Medicine and Associate, Sloan-Kettering Institute for Cancer Research, New York, N. Y.


 

  • References

  • (1) Greig H. B. W. Inhibition of Fibrinolysis by Alimentary Lipemia. Lancet 271: 16 1956;
    PubMedGoogle Scholar
  • (2) Greig H. B. W, Runde I. A. Studies on the Inhibition of Fibrinolysis by Lipids. Lancet 2: 461 1957;
    PubMedGoogle Scholar
  • (3) Gillman T, Naidoo S. S, Hathorn M. Fat, Fibrinolysis, and Atherosclerosis in Africans. Lancet 2: 696 1957;
    PubMedGoogle Scholar
  • (4) Gillman T, Naidoo S. S, Hathorn M. Sex Differences in Plasma Fibrin, Fibrinolytic Capacity, and Lipids as Influenced by Ingested Fat, Gonadectomy, and Hormone Inplants. Clin. Sei. 17: 393 1958;
    PubMedGoogle Scholar
  • (5) Scott R. F, Thomas W. A. Methods for Comparing Effect of Various Fats on Fibrinolysis. Proc. Soc. exp. Biol. (N. Y.) 96: 24 1957;
    CrossrefPubMedGoogle Scholar
  • (6) Burchell A. R, Cliffton E. E. Inhibition of Fibrinolysis by Hyperlipemia. Proc. Soc. exp. Biol. (N. Y.). In Press.
    PubMedGoogle Scholar
  • (7) Kwaan H. C, McFadzean A. J. S. Plasma Fibrinolysis In Vivo by Feeding Cholesterol. Nature 179: 260 1957;
    CrossrefPubMedGoogle Scholar
  • (8) Wessler S. Studies in Intravascular Coagulation. III. Pathogenesis of Serum Introduced Venous Thrombus. J. clin. Invest. 34: 647 1955;
    CrossrefPubMedGoogle Scholar
  • (9) Bang N. U, Freiman A. H, Cliffton E. E. Studies on the Production of Intravascular Thrombi and their Treatment with Fibrinolysin. Submitted for Publication. Circulat. Res..
    PubMedGoogle Scholar
  • (10) Cliffton E. E, Cannamela D. A. Fibrinolytic and Proteolytic Activity of Human Plasminogen, prepared from Fraction III of Human Plasma. J. appi. Physiol. 6: 42 1953;
    PubMedGoogle Scholar
  • (11) Milstone H. A Factor in Normal Human Blood which Participates in Streptococcal Fibrinolysis. J. Immunol. 42: 109 1941;
    PubMedGoogle Scholar
  • (12) Lee R. I, White P. D. A Clinical Study of the Blood Coagulation Time of Blood. Amer. J. med. Sei. 145: 495 1913;
    CrossrefPubMedGoogle Scholar
  • (13) Quick A. S. The Physiology and Pathology of Hemostasis. Henry Kimpton; London: 1951
    Google Scholar
  • (14) Abell L. L, Levy B. B, Brodie B. B, Kendall F. E. A Simplified Method for the Estimation of Total Cholesterol in Serum and Demonstration of its Specificity. J. biol. Chem. 195: 357 1952;
    PubMedGoogle Scholar
  • (15) Zilversmitt D. B, Davis A. K. Microdetermination of Plasma Phospholipids by Trichloracetic Acid Precipitation. J. Lab. clin. Med. 35: 155 1950;
    PubMedGoogle Scholar
  • (16) Owren P, Aas K. The Control of Dicumerol Therapy and the Quantitative Determination of Prothrombin and Proconvertin. Scand. J. clin. Lab. Invest. 3: 201 1951;
    CrossrefPubMedGoogle Scholar
  • (17) Biggs R, MacFarlane R. G. Human Blood Coagulation and its Disorders. Blackwell Press; Oxford: 1957
    Google Scholar
  • (18) Biggs R, Douglass A. S. The Thromboplastin Generation Test. J. clin. Path. 26: 23 1953;
    PubMedGoogle Scholar
  • (19) Mullertz S. Activation of Plasminogen. Ann. N.Y. Acad. Sei 68 (01) 38 1957;
    CrossrefPubMedGoogle Scholar
  • (20) Jacobssen K. Trypsin and Plasmin Inhibitors in Human Blood Serum. Scand J. clin. Lab. Invest.. 7. Suppl. 1955
    PubMedGoogle Scholar
  • (21) Allen J. G, Moulder P. V, Emerson D. M, Glotzer D. The Dynamics of Coagulation. J. Lab. clin. Med. 34: 1579 1949;
    PubMedGoogle Scholar
  • (22) Astrup T. The biological Significance of Fibrinolysis. Lancet 2: 565 1956;
    PubMedGoogle Scholar
  • (23) O’Brien J. R. Fat Ingestion, Blood Coagulation and Atherosclerosis. Amer. J. med. Sei. 234: 373 1957;
    PubMedGoogle Scholar
  • (24) Borrero J, Sheppard E, Wright I. S. Further Experiences with Blood Coagulation after Fat Meals and Carbohydrate Meals. Circulation 17: 936 1958;
    CrossrefPubMedGoogle Scholar
  • (25) Duguid J. B. Thrombosis as a Fact in the Pathogenesis of Coronary Atherosclerosis. J. Path. Bact. 58: 207 1946;
    CrossrefPubMedGoogle Scholar
  • (26) Duguid J. B. Mural Thrombosis in Arteries. Brit. med. Bull. 11: 36 1955;
    CrossrefPubMedGoogle Scholar